Phase I Dose Escalation Study of Pirarubicin in Combination with Cyclophosphamide in Breast Cancer

被引：0
|
作者：
Sakata, M. [1 ]
Jinno, H. [1 ]
Hayashida, T. [1 ]
Takahashi, M. [1 ]
Sato, T. [1 ]
Seki, H. [1 ]
Shimada, K. [1 ]
Nishiya, S. [1 ]
Kitagawa, Y. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Tokyo, Japan
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-10-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-10-13
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dose escalation of cyclophosphamide in patients with breast cancer: Consequences for pharmacokinetics and metabolism
    Kromer, HK
    Busch, FW
    Bohnenstengel, F
    Eichelbaum, M
    Fischer, P
    Opalinska, J
    Schumacher, K
    Schweizer, E
    Busse, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI28 - PI28
  • [22] Dose escalation of cyclophosphamide in patients with breast cancer: Consequences for pharmacokinetics and metabolism
    Busse, D
    Busch, FW
    Bohnenstengel, F
    Eichelbaum, M
    Fischer, P
    Opalinska, J
    Schumacher, K
    Schweizer, E
    Kroemer, HK
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 1885 - 1896
  • [23] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    T Sakiyama
    J Tsurutani
    T Iwasa
    H Kawakami
    Y Nonagase
    T Yoshida
    K Tanaka
    Y Fujisaka
    T Kurata
    Y Komoike
    K Nishio
    K Nakagawa
    British Journal of Cancer, 2015, 112 : 819 - 824
  • [24] A phase I dose-escalation study of eribulin and S-1 for metastatic breast cancer
    Sakiyama, T.
    Tsurutani, J.
    Iwasa, T.
    Kawakami, H.
    Nonagase, Y.
    Yoshida, T.
    Tanaka, K.
    Fujisaka, Y.
    Kurata, T.
    Komoike, Y.
    Nishio, K.
    Nakagawa, K.
    BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 819 - 824
  • [25] A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients
    Zhou, Xinna
    Yu, Jing
    Wang, Wenmiao
    Song, Guohong
    Wang, Xiaoli
    Ren, Jun
    Di, Lijun
    Wang, Xinghe
    SPRINGERPLUS, 2015, 4 : 1 - 6
  • [26] A PHASE I DOSE ESCALATION STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE OF CYCLOPHOSPHAMIDE WHEN GIVEN IN COMBINATION WITH DEXAMETHASONE AND LENALIDOMIDE IN RELAPSE/REFRACTORY MULTIPLE MYELOMA
    Schey, S.
    Morgan, G.
    Davies, F.
    Phekoo, K.
    Ramasamy, K.
    Jenner, M.
    Hazel, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 260 - 260
  • [27] Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics
    Rischin, D
    Ackland, SP
    Smith, J
    Garg, MB
    Clarke, S
    Millward, MJ
    Toner, GC
    Zalcberg, J
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1810 - 1818
  • [28] Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil
    Li, Jun-Jie
    Di, Gen-Hong
    Tang, Li-Chen
    Yu, Ke-Da
    Hu, Zhen
    Liu, Guang-Yu
    Lu, Jing-Song
    Wu, Jiong
    Han, Qi-Xia
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST JOURNAL, 2011, 17 (06): : 657 - 660
  • [29] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Kim, Yeul Hong
    Seo, Hee Yeon
    Jeen, Yoon Tae
    Kim, Hoon-Kyo
    Shim, Byoung Yong
    Yang, Jinmo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 253 - 260
  • [30] Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer
    Yeul Hong Kim
    Hee Yeon Seo
    Yoon Tae Jeen
    Hoon-Kyo Kim
    Byoung Yong Shim
    Jinmo Yang
    Cancer Chemotherapy and Pharmacology, 2009, 63
12345